A new global assay of coagulation and fibrinolysis

Neil Goldenberg, William E. Hathaway, Linda Jacobson, Marilyn J. Manco-Johnson

Research output: Contribution to journalArticle

Abstract

Introduction: Global clotting assays may reflect an individual's net hemostatic balance and could contribute to prothrombotic and hemorrhagic risk assessment. In this research, a global assay that measures both coagulation and fibrinolytic capacities was developed and investigated. Materials and methods: In the Clot Formation and Lysis (CloFAL) assay, a buffered reactant solution containing trace amounts of calcium, tissue factor, and tissue-type plasminogen activator is added to plasma samples on a 96-well microplate in an automated, thermoregulated (37°C) spectrophotometer. Clot formation and lysis are monitored as continuous changes in absorbance over the course of 3 h. Measurements include maximum amplitude (MA), times to maximum absorbance (T 1) and completion of the first phase of decline in absorbance (T 2), and area under the curve (AUC), from which a coagulation index (CI) and various fibrinolytic indices (FI) may be calculated. Results and conclusions: MA, T1, and CI were principally influenced by fibrinogen and procoagulant factors. FI was found to be altered by inhibiting activation of plasminogen or thrombin activatable fibrinolytic inhibitor. Median CI was significantly decreased, while FI was markedly increased, in term neonates as compared to healthy adults (CI: 58% vs. 115%, FI: 210% vs. 90%; P

Original languageEnglish (US)
Pages (from-to)345-356
Number of pages12
JournalThrombosis Research
Volume116
Issue number4
DOIs
StatePublished - 2005
Externally publishedYes

Fingerprint

Plasminogen
Thromboplastin
Fibrinolysis
Tissue Plasminogen Activator
Hemostatics
Thrombin
Fibrinogen
Area Under Curve
Newborn Infant
Calcium
Research

Keywords

  • Coagulation
  • Fibrinolysis
  • Global assay

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology

Cite this

A new global assay of coagulation and fibrinolysis. / Goldenberg, Neil; Hathaway, William E.; Jacobson, Linda; Manco-Johnson, Marilyn J.

In: Thrombosis Research, Vol. 116, No. 4, 2005, p. 345-356.

Research output: Contribution to journalArticle

Goldenberg, N, Hathaway, WE, Jacobson, L & Manco-Johnson, MJ 2005, 'A new global assay of coagulation and fibrinolysis', Thrombosis Research, vol. 116, no. 4, pp. 345-356. https://doi.org/10.1016/j.thromres.2004.12.009
Goldenberg, Neil ; Hathaway, William E. ; Jacobson, Linda ; Manco-Johnson, Marilyn J. / A new global assay of coagulation and fibrinolysis. In: Thrombosis Research. 2005 ; Vol. 116, No. 4. pp. 345-356.
@article{973c261c435747e4a85b7d301211d73c,
title = "A new global assay of coagulation and fibrinolysis",
abstract = "Introduction: Global clotting assays may reflect an individual's net hemostatic balance and could contribute to prothrombotic and hemorrhagic risk assessment. In this research, a global assay that measures both coagulation and fibrinolytic capacities was developed and investigated. Materials and methods: In the Clot Formation and Lysis (CloFAL) assay, a buffered reactant solution containing trace amounts of calcium, tissue factor, and tissue-type plasminogen activator is added to plasma samples on a 96-well microplate in an automated, thermoregulated (37°C) spectrophotometer. Clot formation and lysis are monitored as continuous changes in absorbance over the course of 3 h. Measurements include maximum amplitude (MA), times to maximum absorbance (T 1) and completion of the first phase of decline in absorbance (T 2), and area under the curve (AUC), from which a coagulation index (CI) and various fibrinolytic indices (FI) may be calculated. Results and conclusions: MA, T1, and CI were principally influenced by fibrinogen and procoagulant factors. FI was found to be altered by inhibiting activation of plasminogen or thrombin activatable fibrinolytic inhibitor. Median CI was significantly decreased, while FI was markedly increased, in term neonates as compared to healthy adults (CI: 58{\%} vs. 115{\%}, FI: 210{\%} vs. 90{\%}; P",
keywords = "Coagulation, Fibrinolysis, Global assay",
author = "Neil Goldenberg and Hathaway, {William E.} and Linda Jacobson and Manco-Johnson, {Marilyn J.}",
year = "2005",
doi = "10.1016/j.thromres.2004.12.009",
language = "English (US)",
volume = "116",
pages = "345--356",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - A new global assay of coagulation and fibrinolysis

AU - Goldenberg, Neil

AU - Hathaway, William E.

AU - Jacobson, Linda

AU - Manco-Johnson, Marilyn J.

PY - 2005

Y1 - 2005

N2 - Introduction: Global clotting assays may reflect an individual's net hemostatic balance and could contribute to prothrombotic and hemorrhagic risk assessment. In this research, a global assay that measures both coagulation and fibrinolytic capacities was developed and investigated. Materials and methods: In the Clot Formation and Lysis (CloFAL) assay, a buffered reactant solution containing trace amounts of calcium, tissue factor, and tissue-type plasminogen activator is added to plasma samples on a 96-well microplate in an automated, thermoregulated (37°C) spectrophotometer. Clot formation and lysis are monitored as continuous changes in absorbance over the course of 3 h. Measurements include maximum amplitude (MA), times to maximum absorbance (T 1) and completion of the first phase of decline in absorbance (T 2), and area under the curve (AUC), from which a coagulation index (CI) and various fibrinolytic indices (FI) may be calculated. Results and conclusions: MA, T1, and CI were principally influenced by fibrinogen and procoagulant factors. FI was found to be altered by inhibiting activation of plasminogen or thrombin activatable fibrinolytic inhibitor. Median CI was significantly decreased, while FI was markedly increased, in term neonates as compared to healthy adults (CI: 58% vs. 115%, FI: 210% vs. 90%; P

AB - Introduction: Global clotting assays may reflect an individual's net hemostatic balance and could contribute to prothrombotic and hemorrhagic risk assessment. In this research, a global assay that measures both coagulation and fibrinolytic capacities was developed and investigated. Materials and methods: In the Clot Formation and Lysis (CloFAL) assay, a buffered reactant solution containing trace amounts of calcium, tissue factor, and tissue-type plasminogen activator is added to plasma samples on a 96-well microplate in an automated, thermoregulated (37°C) spectrophotometer. Clot formation and lysis are monitored as continuous changes in absorbance over the course of 3 h. Measurements include maximum amplitude (MA), times to maximum absorbance (T 1) and completion of the first phase of decline in absorbance (T 2), and area under the curve (AUC), from which a coagulation index (CI) and various fibrinolytic indices (FI) may be calculated. Results and conclusions: MA, T1, and CI were principally influenced by fibrinogen and procoagulant factors. FI was found to be altered by inhibiting activation of plasminogen or thrombin activatable fibrinolytic inhibitor. Median CI was significantly decreased, while FI was markedly increased, in term neonates as compared to healthy adults (CI: 58% vs. 115%, FI: 210% vs. 90%; P

KW - Coagulation

KW - Fibrinolysis

KW - Global assay

UR - http://www.scopus.com/inward/record.url?scp=22244485660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22244485660&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2004.12.009

DO - 10.1016/j.thromres.2004.12.009

M3 - Article

VL - 116

SP - 345

EP - 356

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 4

ER -